LIPO LAB V LINE
In fact, LIPO LAB V LINE eliminates fat from the face to achieve the perfect v line. The effect from using results in improved skin elasticity, contour management, skin toning and has a fat reduction effect.
Benefits of this product are:
- As well, it promotes adipocytes.
- Moreover, it is effective for removing cellulites and enhances skin elasticity.
- Additionally, more efficacious, easier treatment and cheaper than liposuction surgery.
- Unlike existing methods such as mesotherapy which only reduces the size of fat cells, Lipo Lab PPC dissolves, destroys fat cells and exhausts them out of body through sweat, urine and internal combustion.
So, how to use LIPO LAB V LINE?
- The product is ready to use. It doesn’t need to mix with other solutions.
- Also, Injection depth 5mm,Injection amount 0.1~0.2cc, Injection interval 1cm.
- It shows the result after 1st treatment, but if side effects occur, additional injection could be done.
- Treatment interval would be 3 days.
However, ingredients of this product are:
Water, horse chestnut extract, Tyrosine, L-carnitine, walnut seed extract, thermophilic.
n
Professional use: Pharmacoline provides commercial product information only and does not provide dosing, dilution, reconstitution, injection, or administration instructions. Qualified professionals should rely on current manufacturer documentation and applicable professional requirements.
LIPO LAB V LINE Product Overview
LIPO LAB V LINE is a product listed in Pharmacoline’s LIPOLYSIS category for qualified professional and commercial purchasers. The product SKU is 549633021579.
Before purchasing, confirm that the product identity, category and listed ingredients meet your requirements. Consult the current product labeling and manufacturer documentation for complete information.
- Product name: LIPO LAB V LINE
- Category: LIPOLYSIS
- SKU: 549633021579
- Ingredients listed on this page: Water, horse chestnut extract, Tyrosine, L-carnitine, walnut seed extract, thermophilic




Reviews
There are no reviews yet.